Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Dihydroberberine Hydrochloride
1. 483-15-8
2. Dihydroberbine
3. Dihydroumbellatine
4. 9,10-dimethoxy-6,8-dihydro-5h-[1,3]dioxolo[4,5-g]isoquinolino[3,2-a]isoquinoline
5. Lambertine
6. 7,8-dihydroberberine
7. Berberine, Dihydro-
8. 9,10-dimethoxy-2,3-(methylenedioxy)-13,13a-didehydroberbine
9. Dihydroberberine/dihydroumbellatine
10. Berbine, 13,13a-didehydro-9,10-dimethoxy-2,3-(methylenedioxy)-
11. 6h-benzo(g)-1,3-benzodioxolo(5,6-a)quinolizine, 5,8-dihydro-9,10-dimethoxy-
12. Nsc331264
13. 16,17-dimethoxy-5,7-dioxa-13-azapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(21),2,4(8),9,15(20),16,18-heptaene
14. 9,10-dimethoxy-5,8-dihydro-6h-[1,3]dioxolo[4,5-g]isoquinolino[3,2-a]isoquinoline
15. Nsc 331264
16. Brn 0344128
17. Lambertin
18. 3bti
19. 4-27-00-06505 (beilstein Handbook Reference)
20. Chembl11848
21. Schembl299738
22. Dtxsid70197476
23. Chebi:192073
24. Hy-n1934
25. Zinc1575028
26. Bdbm50480308
27. Mfcd00022312
28. Akos016010627
29. Nsc-331264
30. Ac-34205
31. Cs-0018246
32. Ft-0701465
33. A14704
34. A871933
35. 9,10-dimethoxy-2,3-(methylenedioxy)-13,13a-didehydrob
36. 9,10-dimethoxy-5,8-dihydro-6h-[1,3]dioxolo[4,5-g]isoquino[3,2-a]isoquinoline
37. 9,10-dimethoxy-5,8-dihydro-6h-[1,3]dioxolo[4,5-g]isoquino[3,2-a]isoquinoline #
38. 9,10-dimethoxy-6,8-dihydro-5h-1,3-dioxolo[4,5-g]isoquinolino[3,2-a]isoquinoline
39. 16,17-dimethoxy-5,7-dioxa-13-azapentacyclo[11.8.0.0^{2,10}.0^{4,8}.0^{15,20}]henicosa-1(21),2(10),3,8,15,17,19-heptaene
| Molecular Weight | 337.4 g/mol |
|---|---|
| Molecular Formula | C20H19NO4 |
| XLogP3 | 3.5 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 2 |
| Exact Mass | 337.13140809 g/mol |
| Monoisotopic Mass | 337.13140809 g/mol |
| Topological Polar Surface Area | 40.2 Ų |
| Heavy Atom Count | 25 |
| Formal Charge | 0 |
| Complexity | 538 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Market Place
ABOUT THIS PAGE
A Dihydroberberine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dihydroberberine, including repackagers and relabelers. The FDA regulates Dihydroberberine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dihydroberberine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Dihydroberberine supplier is an individual or a company that provides Dihydroberberine active pharmaceutical ingredient (API) or Dihydroberberine finished formulations upon request. The Dihydroberberine suppliers may include Dihydroberberine API manufacturers, exporters, distributors and traders.
Dihydroberberine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Dihydroberberine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Dihydroberberine GMP manufacturer or Dihydroberberine GMP API supplier for your needs.
A Dihydroberberine CoA (Certificate of Analysis) is a formal document that attests to Dihydroberberine's compliance with Dihydroberberine specifications and serves as a tool for batch-level quality control.
Dihydroberberine CoA mostly includes findings from lab analyses of a specific batch. For each Dihydroberberine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Dihydroberberine may be tested according to a variety of international standards, such as European Pharmacopoeia (Dihydroberberine EP), Dihydroberberine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Dihydroberberine USP).
LOOKING FOR A SUPPLIER?
